In sum, the above data indicated that FAM225A exhibited higher expression in ESCC tissues and cell lines, and facilitated ESCC progression by accelerating cell viability, migration, and invasion as well as repressing cell apoptosis. Here, FAM225A is linked to esophageal squamous cell carcinoma.